T C Wu

Title: Innovations by T C Wu in Cancer Detection

Introduction

T C Wu is a prominent inventor based in Stevenson, MD (US), known for his significant contributions to the field of cancer detection and analysis. With a total of 5 patents to his name, Wu has been at the forefront of developing innovative technologies that enhance medical diagnostics.

Latest Patents

One of his latest patents focuses on non-invasive cancer detection and analysis through single-molecule imaging. This invention describes chips designed for detecting targets in a sample, which include a microfluidic flow chamber with flow channels featuring a capture surface and at least one micromixer. The methods associated with this chip utilize total internal reflection fluorescence (TIRF) to identify targets effectively. Another notable patent involves compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins. This invention presents a novel fusion protein of Flt3L and albumin, aimed at increasing the Flt3L half-life in vivo and delivering it to immune cells to enhance alternative dendritic cell populations. The use of this fusion protein in combination with various therapeutic methods is also outlined.

Career Highlights

T C Wu is affiliated with The Johns Hopkins University, where he continues to push the boundaries of research and innovation in cancer detection technologies. His work has garnered attention for its potential to revolutionize how cancer is diagnosed and treated.

Collaborations

Wu collaborates with notable colleagues, including Chien-Fu Hung and Brandon Lam, who contribute to his research endeavors and help advance the field of cancer diagnostics.

Conclusion

T C Wu's innovative work in cancer detection exemplifies the impact of research and technology in improving medical diagnostics. His patents reflect a commitment to enhancing patient care through advanced scientific methods.